Skip to main content
. 2018 Mar 16;19(2):275–286. doi: 10.1007/s40257-018-0352-y

Table 2.

Summary of adverse events

AEs A0.3/BPO2.5 side Vehicle side Not side specific Total
n Subject n Subject n Subject n Subject
All AEs 20 14 (20.9) 11 6 (9.0) 125 42 (62.7) 156 47 (70.1)
Treatment-related AEs 16 14 (20.9) 6 6 (9.0) 9 5 (7.5) 31 17 (25.4)
AEs leading to discontinuation 2 2 (3.0) 1 1 (1.5) 0 0 3 2 (3.0)

Data are presented as n and N (%)

AE adverse event, A0.3/BPO2.5 adapalene 0.3%/benzoyl peroxide 2.5% gel